Men who live alone fall short on prostate screening

NEW YORK (Reuters Health) - Men at higher-than-average risk of prostate cancer are more likely to seek regular screening if they are married or live with a significant other, a new study finds.

Researchers found that among more than 2,400 men ages 40 to 79, those with a family history of prostate cancer were more likely to be regularly screened for the disease over a decade. However, a closer look at the data showed that this was only true of men who lived with a wife or partner.

In fact, higher-risk men who lived alone were less apt to seek screening than those with no family history of prostate cancer.

The American Cancer Society recommends that men with a family history of prostate cancer get screened for the disease starting at age 45. However, some studies have found that these men are no more likely to seek screening than those without a family history.

These latest findings, published in the journal Cancer Epidemiology, Biomarkers and Prevention, suggest that partners play a big role in getting men to submit to prostate cancer screening.

“In terms of motivating people to get screened, there may be benefit in targeting wives or significant others as well as men,” lead researcher Lauren P. Wallner, of the University of Michigan in Ann Arbor, noted in a written statement.

The results are based on 2,447 white U.S. men who were taking part in a long-term men’s health study. The researchers used medical records to find out how frequently the men sought prostate cancer screening over roughly a decade; screening included digital rectal examinations and blood tests for prostate-specific antigen (PSA), a protein that can signal prostate cancer.

In general, Wallner’s team found, men with a family history of prostate cancer were 40 percent more likely than those without such a history to frequently seek screening. But when the researchers considered marital status, they found that family history was a motivator only for married or co-habitating men.

On the other hand, men who said they were “worried or concerned” about developing prostate cancer had higher rates of frequent screening regardless of their marital status.

The findings, the researchers write, “provide insight as to how to better promote the benefits of early detection among high-risk men.”

Still, they add, more research is needed to see what factors other than marital status motivate men to get screened.

SOURCE: Cancer Epidemiology, Biomarkers & Prevention, December 2008.


Related Posts:

NEW YORK (Reuters Health) - A study of Vietnam War era veterans shows that exposure to Agent Orange is associated with more than a two-fold increased risk of prostate cancer, earlier disease onset, and prostate cancer with more aggressive features. “Consideration should be made to classify this group of individuals as ‘high risk’, just like men

Full Post: Agent Orange exposure linked to prostate cancer

NEW YORK (Reuters Health) - Cancer news stories and public service announcements that call attention to the fact that African Americans are often diagnosed with cancer at later stages and have lower survival rates than whites may discourage African Americans from getting screened for cancer, new research shows. “We have typically assumed that one of the

Full Post: Negative messages keep blacks from cancer tests

NEW YORK (Reuters Health) - Fathers who are involved in their children’s prenatal care are more likely to be around for the long haul, whether they marry the child’s mother or not, new study findings suggest. The findings, say researchers, suggest that such early involvement — even more so than marriage, per se — is crucial

Full Post: Dad’s involvement during pregnancy is key: study

NEW YORK (Reuters Health) - Drugs used to control diabetes may lower the risk of prostate cancer, investigators at the University of Tampere in Finland report. “Recent studies have reported a decreased prostate cancer risk for diabetic men, although the evidence is controversial,” Dr. Teemu J. Murtola and colleagues note in the American Journal of Epidemiology.

Full Post: Diabetes drugs tied to lower prostate cancer risk

NEW YORK (Reuters Health) - The long-term use of hormone replacement therapy, which older women abandoned in droves following the news that it may increase the risk of breast cancer, may substantially cut the risk of colorectal cancer, research shows. The greatest risk reduction — 48 percent — was observed among women who had used a

Full Post: Hormone therapy may cut colorectal cancer risk

Site Navigation

Most Read